TFT or trifluorothymidine or trifluridine

This classification denotes a pyrimidine antagonist with the molecular formula C10H11F3N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RMW9V5RW38, chemically known as 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-beta-d-ribofuranosyl)-5-(trifluoromethyl)- but generally known as trifluridine, which bears US NIH Compound Identifier 6256. European Medicines Agency schedules Trifluridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11291MIG. The term TRIFLURIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules trifluridine in its Anatomical Therapeutic Chemical (ATC) Classification. TRIFLURIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O.